Short answer
NU SKIN ENTERPRISES, INC. (NUS) filed an 8-K current report with the SEC on August 21, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Justin Keisel began a medical leave August 17, 2026, creating temporary leadership uncertainty for Global Sales.
NU SKIN ENTERPRISES, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Justin Keisel began a medical leave August 17, 2026, creating temporary leadership uncertainty for Global Sales
- COO and Chief Legal Officer Chayce Clark will lead Keisel’s organization during the absence
- No departure, termination, or permanent succession change disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NU SKIN ENTERPRISES, INC. 8-K filings
Get the next NUS 8-K as it lands
Follow NUS for push alerts, or ask the research agent what this filing means.